EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen

Bianca M Coleman, Melissa E Cook, Md Robin Khan, Amanda K Vogel, Anthony J Wells, Jian Miao, Shachi P Vyas, Tiffany C Taylor, Felix E Y Aggor, Nicole O Ponde, Ipsita Dey, Henry Zou und 3 weitere

PLOS Pathogens · 07.05.2026 · 22 (5) · e1014202

DOI: 10.1371/journal.ppat.1014202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 07.05.2026. Verfasst von Bianca M Coleman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Interleukins, Estrogens, Interleukin-17. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvovaginal candidiasis (VVC) affects >75% of women, with considerable morbidity and high medical cost burden. While Type 17 cytokines (IL-17, IL-22) are critical for oral and dermal immunity to C. albicans , their role in VVC has been less clear. Th17 gene signatures are potently upregulated in VVC, yet impairment of individual Th17 components (IL-17A, IL-17R subunits, IL-22) does not worsen disease. Rather, estrogen activity is tightly linked to VVC, leading to a paradigm that hormonal pathways, rather than immune defense, dominate susceptibility. Here, we reveal a previously unappreciated role for IL-1/Type 17 in VVC that operates independently of estrogenic hormones. In contrast to mice lacking IL-17A, IL-17RA, IL-22, or IL-22R individually, mice lacking IL-17RA and IL-22RA1 together ( Il17raIl22ra1 -/- ) exhibited high fungal loads and exacerbated tissue damage and inflammation during estrogen-induced VVC. In human vulvar epithelial cells, IL-17 and IL-22 drive synergistic signaling. IL-1R signaling but surprisingly not IL-23 was upstream of this response. Il17raIl22ra1 -/- mice expressed high IL-1β yet did not control disease, indicating that IL-1 is upstream but not downstream of Type 17 responses. Unexpectedly, Type 17-dependent control occurred in the absence of exogenous estrogen administration and persisted even when estrus was prevented by progesterone treatment. Collectively, these data indicate that susceptibility to VVC is driven not only by estrogen sensitization but through combinatorial loss of IL-17 and IL-22.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candidiasis, VulvovaginalInterleukinsEstrogensInterleukin-17Interleukin-1AnimalsFemaleInterleukin-22MiceMice, KnockoutReceptors, InterleukinHumansReceptors, Interleukin-17Mice, Inbred C57BLCandida albicansTh17 Cells

Substanzen

Interleukin-22InterleukinsEstrogensInterleukin-17Interleukin-1Receptors, Interleukininterleukin-22 receptorReceptors, Interleukin-17

Autor:innen und Institutionen

  • Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Graduate Program in Pharmaceutical Sciences, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
  • Integrated Program in Biomedical Sciences, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis Tennessee, United States of America.
  • Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

ORCID-Profile: Sarah L Gaffen

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Coleman, B. M., Cook, M. E., Khan, M. R., Vogel, A. K., Wells, A. J., Miao, J., Vyas, S. P., Taylor, T. C., Aggor, F. E. Y., Ponde, N. O., Dey, I., Zou, H., Jašarević, E., Peters, B. M., & Gaffen, S. L. (2026). An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen. PLOS Pathogens, 22(5), e1014202. https://doi.org/10.1371/journal.ppat.1014202

Vancouver

Coleman BM, Cook ME, Khan MR, Vogel AK, Wells AJ, Miao J, et al. An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen. PLOS Pathogens. 2026;22(5):e1014202. doi:10.1371/journal.ppat.1014202

BibTeX
@article{Coleman2026,
  author = {Coleman, Bianca M and Cook, Melissa E and Khan, Md Robin and Vogel, Amanda K and Wells, Anthony J and Miao, Jian and Vyas, Shachi P and Taylor, Tiffany C and Aggor, Felix E Y and Ponde, Nicole O and Dey, Ipsita and Zou, Henry and Jašarević, Eldin and Peters, Brian M and Gaffen, Sarah L},
  title = {An IL-1, IL-17, and IL-22 cytokine circuit controls vulvovaginal candidiasis independently of estrogen},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {e1014202},
  doi = {10.1371/journal.ppat.1014202}
}
Kostenlos starten →